Immediate Impact
4 from Science/Nature 73 standout
Citing Papers
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
2024 Standout
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
2024 Standout
Works of J Łopatyński being referenced
Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
2007
Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
2005
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J Łopatyński | 32 | 105 | 98 | 61 | 15 | 227 | |
| Rok Herman | 62 | 86 | 101 | 57 | 17 | 293 | |
| Edoardo Biancalana | 13 | 81 | 113 | 49 | 22 | 283 | |
| Melis Sahinoz | 28 | 78 | 62 | 74 | 18 | 262 | |
| Alejandra Meaney | 30 | 50 | 92 | 35 | 15 | 254 | |
| Jenna M. Rehmer | 18 | 47 | 85 | 53 | 13 | 270 | |
| Norimi Ohashi | 8 | 75 | 88 | 55 | 13 | 274 | |
| Rong-Rong Xie | 10 | 68 | 66 | 39 | 16 | 207 | |
| Ki-Won Oh | 30 | 55 | 92 | 77 | 16 | 283 | |
| Germán D. Carrasquilla | 47 | 65 | 94 | 75 | 11 | 273 | |
| Valérie Turcot | 24 | 124 | 53 | 57 | 14 | 262 |
All Works
Loading papers...